HomeCompareNHNCF vs PFE

NHNCF vs PFE: Dividend Comparison 2026

NHNCF yields 1.34% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHNCF wins by $12.87M in total portfolio value
10 years
NHNCF
NHNCF
● Live price
1.34%
Share price
$115.00
Annual div
$1.54
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.92M
Annual income
$11,298,882.41
Full NHNCF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — NHNCF vs PFE

📍 NHNCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHNCFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHNCF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHNCF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHNCF
Annual income on $10K today (after 15% tax)
$114.13/yr
After 10yr DRIP, annual income (after tax)
$9,604,050.05/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, NHNCF beats the other by $9,581,730.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHNCF + PFE for your $10,000?

NHNCF: 50%PFE: 50%
100% PFE50/50100% NHNCF
Portfolio after 10yr
$6.48M
Annual income
$5,662,570.56/yr
Blended yield
87.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

NHNCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.8
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHNCF buys
0
PFE buys
0
No recent congressional trades found for NHNCF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHNCFPFE
Forward yield1.34%6.13%
Annual dividend / share$1.54$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$12.92M$49.6K
Annual income after 10y$11,298,882.41$26,258.71
Total dividends collected$12.76M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: NHNCF vs PFE ($10,000, DRIP)

YearNHNCF PortfolioNHNCF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$10,969$268.55$9,153$693.39+$1.8KNHNCF
2$12,287$550.57$8,593$849.25+$3.7KNHNCF
3$14,300$1,152.80$8,336$1,066.78+$6.0KNHNCF
4$17,809$2,507.77$8,437$1,384.80+$9.4KNHNCF
5$24,893$5,837.57$9,013$1,875.40+$15.9KNHNCF
6$41,887$15,251.85$10,306$2,680.72+$31.6KNHNCF
7$92,790$47,970.70$12,820$4,101.38+$80.0KNHNCF
8$297,914$198,629.11$17,673$6,826.70+$280.2KNHNCF
9$1,510,778$1,192,009.90$27,543$12,591.86+$1.48MNHNCF
10$12,915,415$11,298,882.41$49,560$26,258.71+$12.87MNHNCF

NHNCF vs PFE: Complete Analysis 2026

NHNCFStock

NAVER Corporation, together with its subsidiaries, provides internet and online search portal, and mobile messenger platform services in South Korea, Japan, and internationally. The company offers Naver, a search portal that offers various content topic boards; LINE, a messaging application; Naver Clova, an integrated AI platform; Papago, an automated interpretation application; WHALE, a web browser; Naver Map, a navigation application; Webtoon, a promotion system for mobile comics; SERIES, a paid content platform; SNOW, a camera; BAND, a mobile community platform; NOW, an audio shows to listen to on NAVER app; and NAVER WORKS, which provides features necessary for work, such as Message, Mail, Calendar, and Drive. It also provides IT platforms, BIZ platforms, advertising services, and NAVER SQUARE for business; NAVER Webtoon, NAVER Webnovel, NAVER AudioClip, Series, Premium Contents, NAVER Influencer Center, Creator Advisor, VIBE, NAVER TV, NAVER Post, and Grafolio for creators; and NAVER D2 Startup Factory, DEVIEW, NAVER D2, NAVER Open Source, CLOVA Platform API, NAVER Maps API, papago API, and NAVER login for developers. In addition, NAVER Corporation is involved in the manufacture of cosmetics; electronic financial business; film production and distribution; real estate rental; investment and information business; and character and doll wholesale and retail activities. The company was formerly known as NHN Corporation. NAVER Corporation was founded in 1999 and is headquartered in Seongnam-si, South Korea.

Full NHNCF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this NHNCF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHNCF vs SCHDNHNCF vs JEPINHNCF vs ONHNCF vs KONHNCF vs MAINNHNCF vs JNJNHNCF vs MRKNHNCF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.